The phase 1b JADE trial found investigational OLN324 produced greater retinal drying in diabetic macular edema and encouraging anatomic, visual, and safety outcomes in wet AMD compared with faricimab.
-
Lifestyle medicine membership has surpassed 17,000 as new CMS reimbursement pathways for shared medical appointments and health coaching may help clinicians integrate prevention-focused care into routine practice.
- IMMUNOLOGYRHEUMATOLOGY
CAR T-Cell Therapy Shows Major Disease Activity Reduction in Refractory Lupus
A pooled analysis of 31 studies involving 243 patients with refractory systemic lupus erythematosus found substantial reductions in SLE disease activity after CAR T-cell therapy, with autologous therapy associated with …
- DERMATOLOGYPHARMACOLOGY
Best Hair Loss Treatments: Minoxidil, Finasteride, PRP and Emerging Therapies
Dermatologists review the evidence for minoxidil, finasteride, dutasteride, spironolactone, PRP, and emerging treatments for male and female pattern hair loss, including efficacy and important safety considerations.
- ENDOCRINOLOGYPEDIATRICS
Semaglutide Reduces BMI in Children Aged 6-11 Years With Obesity: STEP Young Trial
Once-weekly semaglutide substantially reduced BMI in children aged 6 to 11 years with obesity in the phase 3 STEP Young trial, with additional improvements in cardiometabolic measures and no new …
- ENDOCRINOLOGYNEWS/RESEARCHPulmonologySLEEP MEDICINE
Retatrutide Improves Sleep Apnea in Phase 3 Trials
Retatrutide reduced obstructive sleep apnea severity and body weight in two phase 3 trials, including patients with type 2 diabetes. Explore AHI reductions, weight loss, cardiometabolic benefits and safety findings.
- LIFESTYLE MEDICINENeurologyPSYCHIATRY
Exercise Improves Brain Health, ADHD, Depression and Cognition
Exercise may improve brain health, cognition, ADHD symptoms, depression, anxiety and emotional regulation. Discover how dancing, pickleball, aerobic exercise and strength training support mental fitness, neuroplasticity and healthy aging.
Lower-dose CagriSema produced approximately 21% weight loss at 68 weeks in adults with obesity in the phase 3b REDEFINE 9 trial, with both 1.7-mg and 1.0-mg regimens significantly outperforming placebo.
Frailty Increases Dementia and Disability Risk in Older Adults With Arthritis
Frailty was associated with increased risks of dementia, mobility disability and loss of independence in older adults with arthritis, according to a 13-year NHATS analysis presented at ACR Convergence 2026. …
A retrospective study found higher nonvertebral osteoporotic fracture incidence in patients with gout than in matched patients with osteoarthritis or soft-tissue rheumatism, despite lower recorded use of bone-protective therapy.
